Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Triapine-induced Tumor Cell Radiosensitization

  • Read more about Triapine-induced Tumor Cell Radiosensitization
US Application 60/718,172
Filed on 2005-09-16

Polysaccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates

  • Read more about Polysaccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates
US Application 60/731,946
Filed on 2005-10-31

Cyclic Phosphopeptide Inhibitors Of Protein 2c Delta, WIP1

  • Read more about Cyclic Phosphopeptide Inhibitors Of Protein 2c Delta, WIP1
US Application 60/850,218
Filed on 2006-10-06

Modification of Recombinant Ant-tumor RNase (rapLR1) For Optimal Use In The Large-scale Manufacture Of Stable And Potent RapLR1-antibody Conjugatyes

  • Read more about Modification of Recombinant Ant-tumor RNase (rapLR1) For Optimal Use In The Large-scale Manufacture Of Stable And Potent RapLR1-antibody Conjugatyes
US Application 60/722,295
Filed on 2005-09-30

Immunogenic Peptides and Methods of Use For Treating And Preventing Cancer

  • Read more about Immunogenic Peptides and Methods of Use For Treating And Preventing Cancer
US Application 60/733,319
Filed on 2005-11-03

CYP1B1 Genotype

  • Read more about CYP1B1 Genotype
US Application 60/716,439
Filed on 2005-09-12

Development Of A Vaccine Against Human Papillomavirus (HPV) Using A Variant Of The HPV 16 E2 Protein

  • Read more about Development Of A Vaccine Against Human Papillomavirus (HPV) Using A Variant Of The HPV 16 E2 Protein
US Application 60/724,783
Filed on 2005-10-11

Treatment of Viral Infections

  • Read more about Treatment of Viral Infections
US Application 60/741,769
Filed on 2005-12-01

Use Of Replicators To Prevent Gene Silencing

  • Read more about Use Of Replicators To Prevent Gene Silencing
US Application 60/715,113
Filed on 2005-09-07

NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYURETHANE AND POLYUREA POLYMERS, AND COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF

  • Read more about NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYURETHANE AND POLYUREA POLYMERS, AND COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF
US Application 60/987,537
Filed on 2007-11-13

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 151
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • Page 157
  • Page 158
  • Page 159
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health